Detail View
The role of TDP-43 propagation in neurodegenerative diseases: integrating insights from clinical and experimental studies
WEB OF SCIENCE
SCOPUS
- Title
- The role of TDP-43 propagation in neurodegenerative diseases: integrating insights from clinical and experimental studies
- Issued Date
- 2020-10
- Citation
- Experimental & Molecular Medicine, v.52, no.10, pp.1652 - 1662
- Type
- Article
- Keywords
- MUTATIONS ; PRIONS ; PTDP-43 PATHOLOGY ; NUCLEAR IMPORT ; FRONTOTEMPORAL LOBAR DEGENERATION ; AMYOTROPHIC-LATERAL-SCLEROSIS ; TAR-DNA-BINDING ; ALZHEIMERS-DISEASE ; ALPHA-SYNUCLEIN ; AGGREGATION
- ISSN
- 1226-3613
- Abstract
-
TAR DNA-binding protein 43 (TDP-43) is a highly conserved nuclear RNA/DNA-binding protein involved in the regulation of RNA processing. The accumulation of TDP-43 aggregates in the central nervous system is a common feature of many neurodegenerative diseases, such as amyotrophic lateral sclerosis (ALS), frontotemporal dementia (FTD), Alzheimer’s disease (AD), and limbic predominant age-related TDP-43 encephalopathy (LATE). Accumulating evidence suggests that prion-like spreading of aberrant protein aggregates composed of tau, amyloid-β, and α-synuclein is involved in the progression of neurodegenerative diseases such as AD and PD. Similar to those of prion-like proteins, pathological aggregates of TDP-43 can be transferred from cell-to-cell in a seed-dependent and self-templating manner. Here, we review clinical and experimental studies supporting the prion-like spreading of misfolded TDP-43 and discuss the molecular mechanisms underlying the propagation of these pathological aggregated proteins. The idea that misfolded TDP-43 spreads in a prion-like manner between cells may guide novel therapeutic strategies for TDP-43-associated neurodegenerative diseases. © 2020, The Author(s).
더보기
- Publisher
- Springer Nature
File Downloads
- There are no files associated with this item.
공유
Total Views & Downloads
???jsp.display-item.statistics.view???: , ???jsp.display-item.statistics.download???:
